RecruitingMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Sleep Apnea in Patients With MGUS and MM
Eligible age
18–99 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.
Sponsor: Michael Tomasson
Where it's recruiting
Iowa
Iowa City
Source: ClinicalTrials.gov · NCT04114084 · last updated 2025-11-10